KUALA LUMPUR: Solution Group Bhd
said wholly-owned subsidiary Solution Biologics Sdn Bhd (SolBio) has signed a term sheet agreement with the Ministry of Health (MoH) for the supply of Covid-19 vaccine.
"The term sheet agreement, signed on Jan 29, is to enable SolBio to enter into a definitive supply agreement to supply 3.5 million doses of the Recombinant Ad5-nCoV vaccine," the company said in a filing today.
The vaccine, Solution Group said, was jointly developed by CanSino Biologics Inc and Beijing Institute of Biotechnology, Academy of Military Medical Sciences.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
